% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Oster:303111,
author = {C. Oster$^*$ and A. Matyar and T. Schmidt and T. Hummel and
E. Hattingen and M. Jokisch and D. Jokisch and J. Grieger
and G. Cappello and K. Kizina and L. Lazaridis and Y.
Ahmadipour and L. Rauschenbach$^*$ and M. Stuschke and C.
Pöttgen and N. Guberina and T. Tertel and B. Giebel and G.
L. Dreizner and F. Barbato$^*$ and E.-M. Skoda and B.
Scheffler$^*$ and M. Müther and K. Herrmann$^*$ and C.
Kleinschnitz and U. Sure and C. Deuschl and M. Glas$^*$ and
S. Kebir},
title = {{D}ecoding glioblastoma survival: unraveling the prognostic
potential of olfactory function in a prospective
observational study.},
journal = {Neurological research and practice},
volume = {7},
number = {1},
issn = {2524-3489},
address = {[London]},
publisher = {BioMed Central},
reportid = {DKFZ-2025-01530},
pages = {51},
year = {2025},
abstract = {Olfactory impairment is common in glioblastoma and has been
associated with unfavorable overall survival. However, prior
studies were limited by imbalances in key prognostic factors
and the absence of longitudinal olfactory assessments to
evaluate treatment-related neurotoxicity. The aim of the
study is to determine whether olfactory function serves as
an independent prognostic marker for survival,
neurocognitive outcomes, and quality of life in
glioblastoma.Prospective, multicenter cohort study enrolling
64 glioblastoma patients and 64 matched healthy controls.
Patients are stratified by extent of resection,
O6-Methylguanine-DNA Methyltransferase promoter methylation,
radiographic involvement of olfactory regions, baseline
olfactory status, age, and Karnofsky performance status.
Olfactory function is assessed serially using Sniffin'
Sticks (identification and threshold tests) from diagnosis
through treatment. Coronal T2- and T1-weighted MRI scans are
reviewed independently by two blinded neuroradiologists to
detect olfactory region involvement. Neurocognitive testing,
psychosocial screening, and quality of life assessments are
conducted at defined intervals. Next-generation sequencing
from tumor tissue is employed to explore molecular
underpinnings of hyposmia. Blood samples are collected in
every study visit for potential parallel translational
studies.This is the first longitudinal study evaluating
olfactory function as a prognostic biomarker in
glioblastoma. Findings may inform risk stratification, guide
neuroprotective strategies, and improve survivorship
care.ClinicalTrials.gov, NCT06954636, date of registration
04-16-2025 (retrospectively registered);
$https://clinicaltrials.gov/study/NCT06954636?cond=glioblastoma\&intr=olfactory\&rank=1$
.},
keywords = {Glioblastoma (Other) / Identification test (Other) /
Olfactory dysfunction (Other) / Prognosis (Other) /
Threshold test (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40708059},
doi = {10.1186/s42466-025-00410-2},
url = {https://inrepo02.dkfz.de/record/303111},
}